King Charles returns to public duties following a hospital visit due to minor side effects from cancer treatment. The 76-year-old monarch had been receiving treatment since last year's cancer ...

IT’S only normal to change a little from mid-life – greying hair, wrinkles, aching limbs and the odd ‘senior moment’. But some symptoms usually associated with ageing shouldn’t just be ...

Britain's King Charles is returning to public duties this week after he was briefly taken to hospital last Thu ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved trofolastat (RoTecPSMA), the first prostate-specific membrane antigen (PSMA)-targeting product authorised for use with ...

The radioligand agent is now approved for use before chemotherapy in patients who have been treated with an androgen receptor pathway inhibitor.

Pancreatic cancer is on the rise in the United States, but there's another, less common type called pancreatic neuroendocrine ...